Edesa Biotech Inc (EDSA)

4.449 +0.08 (+1.81%) USD  |  NASDAQ  |  Jun 14, 16:00
4.33 -0.12 (-2.68%) After-Hours: 20:00
More

Edesa Biotech Research and Development Expense (TTM): 3.860M for March 31, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2011. Upgrade now.
Date Value
March 31, 2024 3.860M
December 31, 2023 4.142M
September 30, 2023 4.794M
June 30, 2023 5.635M
March 31, 2023 9.157M
December 31, 2022 10.74M
September 30, 2022 13.34M
June 30, 2022 15.67M
March 31, 2022 15.59M
December 31, 2021 20.52M
September 30, 2021 17.95M
June 30, 2021 14.97M
March 31, 2021 11.65M
December 31, 2020 4.181M
September 30, 2020 3.330M
June 30, 2020 2.656M
March 31, 2020 2.016M
December 31, 2019 1.888M
September 30, 2019 1.831M
June 30, 2019 1.846M
March 31, 2019 1.808M
December 31, 2018 1.927M
September 30, 2018 2.087M
June 30, 2018 2.237M
March 31, 2018 2.308M
Date Value
December 31, 2017 2.144M
September 30, 2017 1.973M
June 30, 2017 1.988M
March 31, 2017 1.922M
December 31, 2016 1.902M
September 30, 2016 1.729M
June 30, 2016 1.267M
March 31, 2016 0.927M
December 31, 2015 0.8995M
September 30, 2015 1.030M
June 30, 2015 1.918M
March 31, 2015 2.251M
December 31, 2014 2.506M
August 31, 2014 2.459M
May 31, 2014 2.704M
February 28, 2014 2.420M
November 30, 2013 2.121M
August 31, 2013 2.019M
May 31, 2013 2.099M
February 28, 2013 2.253M
November 30, 2012 2.391M
August 31, 2012 2.634M
May 31, 2012 1.046M
February 29, 2012 1.136M
November 30, 2011 1.056M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

1.831M
Minimum
Sep 2019
20.52M
Maximum
Dec 2021
8.288M
Average
5.215M
Median

Research and Development Expense (TTM) Benchmarks

Acasti Pharma Inc 4.638M
Aurinia Pharmaceuticals Inc 49.64M
Lexaria Bioscience Corp 2.961M
Xenon Pharmaceuticals Inc 172.25M
ESSA Pharma Inc 23.05M